Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy.

Bird, N T E; Elmasry, M; Jones, R; Psarelli, E; Dodd, J; Malik, H; Greenhalf, W; Kitteringham, N; Ghaneh, P; Neoptolemos, J P; Palmer, D

Bird, N T E; Elmasry, M; Jones, R; Psarelli, E; Dodd, J; Malik, H; Greenhalf, W; Kitteringham, N; Ghaneh, P; Neoptolemos, J P; Palmer, D.

Afiliación

Bird NT; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Elmasry M; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Jones R; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Psarelli E; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Dodd J; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Malik H; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Greenhalf W; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Kitteringham N; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Ghaneh P; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Neoptolemos JP; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.
Palmer D; Liverpool University Pharmacology Unit, Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool L69 3BX, UK.

Br J Surg ; 104(4): 328-336, 2017 Mar.

Article en En | MEDLINE | ID: mdl-28199010

Asunto(s)

Antimetabolitos Antineoplásicos/uso terapéutico; Biomarcadores de Tumor/metabolismo; Carcinoma Ductal Pancreático/tratamiento farmacológico; Desoxicitidina/análogos & derivados; Tranportador Equilibrativo 1 de Nucleósido/metabolismo; Neoplasias Pancreáticas/tratamiento farmacológico; Carcinoma Ductal Pancreático/metabolismo; Carcinoma Ductal Pancreático/mortalidad; Quimioterapia Adyuvante; Desoxicitidina/uso terapéutico; Supervivencia sin Enfermedad; Humanos; Neoplasias Pancreáticas/metabolismo; Neoplasias Pancreáticas/mortalidad; Pronóstico; Gemcitabina

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Biomarcadores de Tumor / Carcinoma Ductal Pancreático / Tranportador Equilibrativo 1 de Nucleósido / Desoxicitidina / Antimetabolitos Antineoplásicos Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Br J Surg Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google